QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 170 filers reported holding QIAGEN NV in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $9,664,000 | +1.3% | 344,906 | -0.8% | 0.02% | 0.0% |
Q3 2016 | $9,544,000 | +26.4% | 347,826 | +0.5% | 0.02% | +17.6% |
Q2 2016 | $7,550,000 | -3.3% | 346,156 | -1.0% | 0.02% | -5.6% |
Q1 2016 | $7,809,000 | +12.4% | 349,546 | +39.1% | 0.02% | +12.5% |
Q4 2015 | $6,949,000 | +6.7% | 251,320 | -0.4% | 0.02% | 0.0% |
Q3 2015 | $6,511,000 | +0.2% | 252,380 | -3.7% | 0.02% | +6.7% |
Q2 2015 | $6,496,000 | -8.1% | 262,050 | -6.5% | 0.02% | -6.2% |
Q1 2015 | $7,065,000 | +6.7% | 280,370 | -0.6% | 0.02% | 0.0% |
Q4 2014 | $6,620,000 | +2.7% | 282,170 | -0.3% | 0.02% | 0.0% |
Q3 2014 | $6,448,000 | -5.3% | 283,160 | +1.7% | 0.02% | 0.0% |
Q2 2014 | $6,811,000 | +23.1% | 278,560 | +6.1% | 0.02% | +23.1% |
Q1 2014 | $5,535,000 | -10.1% | 262,460 | +1.5% | 0.01% | -13.3% |
Q4 2013 | $6,154,000 | +10.9% | 258,480 | -0.3% | 0.02% | 0.0% |
Q3 2013 | $5,551,000 | +9.3% | 259,380 | +1.6% | 0.02% | +7.1% |
Q2 2013 | $5,081,000 | – | 255,180 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Exane Asset Management | 642,752 | $14,260,214,000 | 5.53% |
Tikvah Management LLC | 369,425 | $8,057,000 | 4.72% |
Hardman Johnston Global Advisors LLC | 3,797,024 | $82,813,000 | 4.22% |
HealthCor Management, L.P. | 2,500,000 | $54,525,000 | 2.97% |
Opus Point Partners Management, LLC | 105,751 | $2,306,000 | 2.23% |
CRAMER ROSENTHAL MCGLYNN LLC | 4,018,074 | $87,634,000 | 1.41% |
Douglas Lane & Associates, LLC | 1,942,678 | $42,370,000 | 1.22% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,167,768 | $47,279,000 | 1.17% |
MANNING & NAPIER ADVISORS LLC | 6,111,364 | $133,287,000 | 0.81% |
PRIMECAP MANAGEMENT CO/CA/ | 20,128,325 | $438,999,000 | 0.47% |